Ingevity Corp
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
NGVT$60.78-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| In millions, except share and par value data | 2024 | 2023 |
| Assets | ||
| Cash and cash equivalents | $68.0 | $95.9 |
| Accounts receivable, net of allowance of $0.6 million - 2024 and $1.1 million - 2023 | 141.0 | 182.0 |
| Inventories, net | 226.8 | 308.8 |
| Prepaid and other current assets | 57.4 | 71.9 |
| Current assets | 493.2 | 658.6 |
| Property, plant, and equipment, net | 658.9 | 762.2 |
| Operating lease assets, net | 50.4 | 67.1 |
| Goodwill | 175.2 | 527.5 |
| Other intangibles, net | 278.8 | 336.1 |
| Deferred income taxes | 117.9 | 11.6 |
| Restricted investment, net of allowance of $0.2 million - 2024 and $0.2 million - 2023 | 81.6 | 79.1 |
| Strategic investments | 87.3 | 99.2 |
| Other assets | 79.3 | 81.9 |
| Total Assets | $2,022.6 | $2,623.3 |
| Liabilities | ||
| Accounts payable | $94.5 | $158.4 |
| Accrued expenses | 58.1 | 72.3 |
| Accrued payroll and employee benefits | 27.7 | 19.9 |
| Current operating lease liabilities | 16.9 | 18.7 |
| Notes payable and current maturities of long-term debt | 61.3 | 84.4 |
| Income taxes payable | 5.6 | 9.2 |
| Current liabilities | 264.1 | 362.9 |
| Long-term debt including finance lease obligations | 1,339.7 | 1,382.8 |
| Noncurrent operating lease liabilities | 36.8 | 48.6 |
| Deferred income taxes | 56.2 | 70.9 |
| Other liabilities | 130.6 | 126.7 |
| Total Liabilities | 1,827.4 | 1,991.9 |
| Commitments and contingencies (Note 18) | ||
| Equity | ||
| Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2024 and 2023) | — | — |
| Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,630,211 and 43,446,513 issued and 36,350,425 and 36,233,092 outstanding at 2024 and 2023, respectively) | 0.4 | 0.4 |
| Additional paid-in capital | 176.8 | 164.9 |
| Retained earnings | 572.0 | 1,002.3 |
| Accumulated other comprehensive income (loss) | (41.4) | (26.7) |
| Treasury stock, common stock, at cost (7,279,786 shares - 2024 and 7,213,421 shares - 2023) | (512.6) | (509.5) |
| Total Equity | 195.2 | 631.4 |
| Total Liabilities and Equity | $2,022.6 | $2,623.3 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.